Cboe CA - Free Realtime Quote CAD
Cybin Inc. (CYBN.NE)
9.55
+0.41
+(4.49%)
As of 12:38:32 PM EDT. Market Open.
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
0
0
0
0
864
Cost of Revenue
--
--
--
0
664
Gross Profit
--
--
--
0
200
Operating Expense
135,070
78,836
51,518
63,838
30,724
Operating Income
-135,070
-78,836
-51,518
-63,838
-30,524
Net Non Operating Interest Income Expense
7,190
619
603
241
50
Other Income Expense
23,976
137
3,425
-4,034
-1,746
Pretax Income
-103,904
-78,080
-47,490
-67,631
-32,220
Net Income Common Stockholders
-103,904
-78,080
-47,490
-67,631
-32,220
Diluted NI Available to Com Stockholders
-103,904
-78,080
-47,490
-67,631
-32,220
Basic EPS
-4.96
-9.50
-9.88
-15.20
-12.16
Diluted EPS
-4.96
-9.50
-9.88
-15.20
-12.16
Basic Average Shares
18,388.76
8,297.37
4,879.70
4,402.30
2,631.86
Diluted Average Shares
20,001.41
8,297.37
4,879.70
4,402.30
2,631.86
Total Expenses
135,070
78,836
51,518
63,838
31,388
Net Income from Continuing & Discontinued Operation
-103,904
-78,080
-47,490
-67,631
-32,220
Normalized Income
-127,908
-78,217
-50,915
-63,597
-30,474
Interest Income
7,190
619
603
241
60
Interest Expense
--
--
--
0
10
Net Interest Income
7,190
619
603
241
50
EBIT
-135,070
-78,836
-51,518
-63,838
-32,210
EBITDA
-134,515
-78,412
-51,267
-63,670
-32,161
Reconciled Cost of Revenue
--
--
--
0
664
Reconciled Depreciation
555
424
251
168
49
Net Income from Continuing Operation Net Minority Interest
-103,904
-78,080
-47,490
-67,631
-32,220
Total Unusual Items Excluding Goodwill
24,004
137
3,425
-4,034
-1,746
Total Unusual Items
24,004
137
3,425
-4,034
-1,746
Normalized EBITDA
-158,519
-78,549
-54,692
-59,636
-30,415
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2021 - 11/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHRM.CN PharmaTher Holdings Ltd.
0.2100
-4.55%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1350
+3.85%
ATAI Atai Life Sciences N.V.
1.4100
+0.71%
MNMD Mind Medicine (MindMed) Inc.
6.16
-4.64%
ONC.TO Oncolytics Biotech Inc.
0.7200
0.00%
PHRRF PharmaTher Holdings Ltd.
0.1620
+1.25%
1KA.MU GH Research PLC
9.40
0.00%
DRUG.CN Bright Minds Biosciences Inc.
46.03
+4.19%
BETR.CN BetterLife Pharma Inc.
0.0850
-10.53%
MDNA.TO Medicenna Therapeutics Corp.
1.0700
+7.00%